Palladium-catalyzed C–C coupling: efficient preparation of new 5-thio-β-d-xylopyranosides as oral venous antithrombotic drugs
摘要:
First examples of a Suzuki and Stille cross-coupling reaction to prepare derivatives of pyridinyl 5-thio-beta-D-xylopyranosides are described. Some of these compounds are orally active in an animal model of venous thrombosis. (c) 2009 Elsevier Ltd. All rights reserved.
Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics
申请人:Barberousse Veronique
公开号:US20080293768A1
公开(公告)日:2008-11-27
The invention relates to novel 5-thioxylose compounds, preferably derivatives of the 5-thioxylopyranose type, to the process for their preparation and to their use as active principles of drugs intended especially for the treatment or prevention of thrombosis or cardiac insufficiency.
NOUVEAUX COMPOSES DERIVES DU 5-THIOXYLOSE ET LEUR UTILISATION THERAPEUTIQUE
申请人:LABORATOIRES FOURNIER S.A.
公开号:EP1861411A2
公开(公告)日:2007-12-05
US8148407B2
申请人:——
公开号:US8148407B2
公开(公告)日:2012-04-03
[EN] NOVEL COMPOUNDS DERIVED FROM 5-THIOXYLOSE AND THERAPEUTIC USE THEREOF<br/>[FR] NOUVEAUX COMPOSES DERIVES DU 5-THIOXYLOSE ET LEUR UTILISATION THERAPEUTIQUE
申请人:FOURNIER LAB SA
公开号:WO2006100413A2
公开(公告)日:2006-09-28
(EN) The invention relates to novel compounds derived from 5-thioxylose, preferably 5-thioxylopyranose-type derivatives, and to the preparation method thereof and the use of same as an active principle in medicaments which are intended, for example, for the treatment or prevention of thromboses or heart failure.(FR) L'invention concerne de nouveaux composés du 5-thioxylose, préférentiellement des dérivés de type 5-thioxylopyranose, ainsi que leur procédé de préparation et leur utilisation en tant que principe actif de médicaments, notamment destinés au traitement ou à la prévention des thromboses ou de l'insuffisance cardiaque.
Palladium-catalyzed C–C coupling: efficient preparation of new 5-thio-β-d-xylopyranosides as oral venous antithrombotic drugs
First examples of a Suzuki and Stille cross-coupling reaction to prepare derivatives of pyridinyl 5-thio-beta-D-xylopyranosides are described. Some of these compounds are orally active in an animal model of venous thrombosis. (c) 2009 Elsevier Ltd. All rights reserved.